| Medical and Health Sciences | 2021-2025 | 69 | AT 1 | 99.99 |
| Epidemiology | Lifetime | 73 | AT 1 | 99.88 |
| Infectious Diseases | Lifetime | 85 | AT 1 | 99.73 |
| Immunology | Lifetime | 544 | AT 4 | 98.42 |
| Infectious Diseases | 2021-2025 | 1 | AT 1 | 99.96 |
| Epidemiology | 2021-2025 | 19 | AT 1 | 99.92 |
| Immunology | 2021-2025 | 55 | AT 1 | 98.92 |
| COVID-19 Clinical Research Studies | Lifetime | 11 | AT 1 | 99.90 |
| Respiratory viral infections research | Lifetime | 11 | AT 1 | 99.88 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 12 | AT 1 | 99.89 |
| Influenza Virus Research Studies | Lifetime | 14 | AT 1 | 99.87 |
| SARS-CoV-2 detection and testing | Lifetime | 13 | AT 1 | 99.48 |
| Immune Response and Inflammation | Lifetime | 185 | AT 1 | 99.49 |
| Animal Disease Management and Epidemiology | Lifetime | 127 | AT 1 | 99.09 |
| COVID-19 epidemiological studies | Lifetime | 265 | AT 1 | 97.95 |
| Viral gastroenteritis research and epidemiology | Lifetime | 607 | AT 2 | 98.33 |
| Vaccine Coverage and Hesitancy | Lifetime | 323 | AT 2 | 97.70 |
| interferon and immune responses | Lifetime | 508 | AT 4 | 96.79 |
| Long-Term Effects of COVID-19 | Lifetime | 922 | AT 11 | 94.42 |
| Viral Infections and Outbreaks Research | Lifetime | 625 | AT 1 | 94.92 |
| Immune responses and vaccinations | Lifetime | 408 | AT 2 | 89.64 |
| COVID-19 Impact on Reproduction | Lifetime | 862 | AT 3 | 86.97 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 2 | AT 1 | 99.97 |
| COVID-19 Clinical Research Studies | 2021-2025 | 3 | AT 1 | 99.96 |
| Influenza Virus Research Studies | 2021-2025 | 1 | AT 1 | 99.94 |
| Respiratory viral infections research | 2021-2025 | 3 | AT 1 | 99.83 |
| SARS-CoV-2 detection and testing | 2021-2025 | 10 | AT 1 | 99.40 |
| Viral gastroenteritis research and epidemiology | 2021-2025 | 23 | AT 1 | 98.70 |
| Immune Response and Inflammation | 2021-2025 | 11 | AT 1 | 98.45 |
| Animal Disease Management and Epidemiology | 2021-2025 | 21 | AT 1 | 98.87 |
| Vaccine Coverage and Hesitancy | 2021-2025 | 62 | AT 2 | 98.61 |
| Animal Virus Infections Studies | 2021-2025 | 61 | AT 1 | 97.28 |
| Monoclonal and Polyclonal Antibodies Research | 2021-2025 | 108 | AT 1 | 97.63 |
| Immune responses and vaccinations | 2021-2025 | 23 | AT 1 | 96.12 |
| interferon and immune responses | 2021-2025 | 107 | AT 1 | 94.30 |
| Immunotherapy and Immune Responses | 2021-2025 | 353 | AT 1 | 95.48 |
| Immune Cell Function and Interaction | 2021-2025 | 683 | AT 4 | 93.01 |
| COVID-19 epidemiological studies | 2021-2025 | 488 | AT 1 | 94.18 |
| Viral Infections and Vectors | 2021-2025 | 440 | AT 5 | 93.58 |
| Viral Infections and Outbreaks Research | 2021-2025 | 321 | AT 1 | 88.82 |
| vaccines and immunoinformatics approaches | 2021-2025 | 652 | AT 2 | 78.84 |
| Virology and Viral Diseases | 2021-2025 | 525 | AT 3 | 76.03 |
